医学部

原田 将英

ハラダ マサヒデ  (harada masahide)

基本情報

所属
藤田医科大学 医学部 医学科 循環器内科学 准教授

J-GLOBAL ID
200901026008784300
researchmap会員ID
6000014004

専門:臨床不整脈・心臓電気生理学 基礎電気生理学 カテーテルアブレーション ペースメーカー/ICD/CRTD

日本内科学会 総合内科専門医
日本循環器学会 専門医
日本不整脈心電学会 専門医(評議員)
日本心血管インターベンション治療学会 認定医
欧州心臓病学会 特別正会員(FESC)

学歴

 2

論文

 122
  • Laurent Macle, Frederic Sebag, Teiichi Yamane, Jean Champagne, Jose Romero, Daniel Scherr, Jean-François Roux, Marc W. Deyell, Hidemori Hayashi, Guy Amit, Mouhannad Sadek, Paul Novak, Peter M. Kistler, Massimo Grimaldi, Vidal Essebag, Alexandre Raymond-Paquin, Ivo Roca-Luque, Prashanthan Sanders, Paul Zei, Pablo Nery, Katia Dyrda, Jacqueline Joza, Christian Steinberg, Andrew Ha, Ken Quadros, Masahide Harada, Jason Andrade, Atul Verma
    American Heart Journal 107632-107632 2026年10月  査読有り
  • Yuji Matsuwaki, Junichiro Hayano, Hideki Kawai, Yusuke Funato, Masanobu Yanase, Masahide Harada, Eiichi Watanabe, Norihiro Ueda, Masatoshi Yamazaki, Naoki Tomii, Ichiro Sakuma, Hideo Izawa
    International Heart Journal 67(5) 464-472 2026年9月30日  査読有り
  • Masanaru Sawada, Koichi Nagashima, Ryuta Watanabe, Yuji Saito, Yuji Wakamatsu, Naoto Otsuka, Shu Hirata, Moyuru Hirata, Hikaru Masuda, Akinori Matsushima, Masato Sakaki, Shiro Nakahara, Hirotsugu Sato, Hideyuki Aoki, Yuta Kimura, Hidehira Fukaya, Masahide Harada, Yuji Motoike, Mitsuru Takami, Yasuo Okumura
    Europace 28(9) euag218 2026年8月21日  査読有り
    Abstract Clinical trial registration: UMIN Clinical Trials Registry, UMIN000057894.
  • Yukio Ozaki, Akihiro Tobe, Yoshinobu Onuma, Kotaro Miyashita, Yoshio Kobayashi, Tetsuya Amano, Kyohei Yamaji, Hideki Ishii, Takashi Muramatsu, Tevfik F. Ismail, Shun Kohsaka, Yoshihisa Nakagawa, Yoshihiro Morino, Shiro Uemura, Kenichi Tsujita, Toshiro Shinke, Junya Ako, Junji Yajima, Yuichiro Maekawa, Junya Shite, Yasumi Igarashi, Nobuo Shiode, Atsunori Okamura, Takayuki Ogawa, Junichi Yamaguchi, Toshihiro Tamura, Takafumi Tsuji, Kentaro Hayashida, Teruyasu Sugano, Hiroyuki Okura, Hideki Okayama, Katsuhiro Kawaguchi, Kan Zen, Saeko Takahashi, Kazuhiko Nakazato, Nobuhiro Suematsu, Kiyoshi Hironaga, Tetsuya Matoba, Osamu Iida, Masaharu Ishihara, Masaya Ohta, Masahide Harada, Reina Ozaki, Hideo Izawa, Toyoaki Murohara, Takafumi Ueno, Masato Nakamura, Yuji Ikari, Patrick W. Serruys, Ken Kozuma
    Cardiovascular Intervention and Therapeutics 41(2) 209-255 2026年2月26日  査読有り
    Abstract Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178–203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1–34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335–375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.
  • Masanaru Sawada, Hirotsugu Sato, Koichi Nagashima, Ryuta Watanabe, Yuji Saito, Yuji Wakamatsu, Naoto Otsuka, Shu Hirata, Moyuru Hirata, Shiro Nakahara, Kennosuke Yamashita, Daiki Kumazawa, Yu-Ki Iwasaki, Yuhi Fujimoto, Masahide Harada, Hitoshi Mori, Kazuhisa Matsumoto, Keiichi Ashikaga, Hiroyuki Takekawa, Takayuki Otsuka, Atsuhiko Yagishita, Yoshihisa Naruse, Kazuki Ito, Yasuo Okumura
    Heart rhythm O2 7(2) 221-231 2026年2月  
    BACKGROUND: Pulsed field ablation (PFA) is a novel therapy for atrial fibrillation (AF) with myocardial selectivity and safety. The VARIPULSE catheter (variable-loop circular catheter [VLCC]; Biosense Webster, Inc.) was recently introduced in Japan, but multicenter real-world data remain scarce. OBJECTIVE: This study aimed to evaluate procedural features, acute safety, and early outcomes of tissue proximity indication (TPI)-guided PFA under structured training and standardized protocols. METHODS: We retrospectively analyzed 387 consecutive patients with AF (66.4 ± 10.9 years, 69% male, 87.1% paroxysmal) undergoing initial pulmonary vein isolation (PVI) with the VLCC at 10 Japanese centers (April 2024-May 2025). TPI-guided first-pass PVI targeted ≥12 applications per vein in 4 sets (proximal/distal), with additional ablation at TPI-negative sites. Operators received training and followed a harmonized workflow emphasizing TPI guidance and sheath management. RESULTS: First-pass PVI was achieved in 360 patients (93.0%). After limited touch-up (6.9 ± 3.6 applications), complete PVI was obtained in all. Mean PVI time was 32.1 minutes, procedure duration 89.7 minutes, and median fluoroscopy time 3.0 minutes. Three patients (0.8%) had vascular complications; no tamponade, stroke, transient ischemic attack, or renal injury occurred. Predictors of first-pass failure were higher body mass index and lack of pre-mapping, mainly in early cases, declining from 11.4% to 3.0% (P < .001). At median follow-up of 182 days, arrhythmia-free survival was 94.1% at 3 months and 88.5% at 6 months. CONCLUSION: In this first multicenter real-world study, TPI-guided PFA with the VLCC demonstrated high acute efficacy, no clinical strokes or TIAs, low complication rates, and favorable mid-term outcomes with structured training and standardized protocols.

MISC

 70

書籍等出版物

 29

講演・口頭発表等

 6

共同研究・競争的資金等の研究課題

 11